Printer Friendly

Browse Cardiovascular diseases topic

Drug therapy subtopic

Articles

1-273 out of 273 article(s)
Title Author Type Date Words
Ray of hope with once-weekly treatment of diabetes. Disease/Disorder overview Oct 26, 2020 617
SGLT2 inhibitors show clinically meaningful effects in patients without diabetes. Zoler, Mitchel L. Aug 1, 2020 1944
Are We Finally Reaching Consensus About Fish Oil? Faloon, William Aug 1, 2020 3461
Cardiovascular death benefit lacking with ertugliflozin. Zoler, Mitchel L. Jul 1, 2020 1297
The Mechanism of Metabolic Influences on the Endogenous GLP1 by Oral Antidiabetic Medications in Type 2 Diabetes Mellitus. Nguyen, Thiquynhnga; Gong, Min; Wen, Song; Yuan, Xinlu; Wang, Chaoxun; Jin, Jianlan; Zhou, Ligang Jun 30, 2020 8454
Natural Products: Optimizing Cancer Treatment through Modulation of Redox Balance. Rijo, Patricia; Pesic, Milica; Fernandes, Ana S.; Santos, Claudia N. Jun 30, 2020 1586
Amarin to increase Vascepa promotion and education initiatives. Jun 1, 2020 220
Cardiovigilance in COVID 19. Kishor, Kamal; Marwah, Rishabh; Anantharaj, Avinash Report May 31, 2020 1992
Network Pharmacology-Based Approach to Investigate the Mechanisms of Mahai Capsules in the Treatment of Cardiovascular Diseases. Shi, Minjuan; Li, Bo; Yuan, Qiuzhen; Gan, Xuefeng; Ren, Xiao; Jiang, Shanshan; Liu, Zhuo May 31, 2020 7092
Improved Landmark Dynamic Prediction Model to Assess Cardiovascular Disease Risk in On-Treatment Blood Pressure Patients: A Simulation Study and Post Hoc Analysis on SPRINT Data. Sayadi, Mehrab; Zare, Najaf; Attar, Armin; Ayatollahi, Seyyed Mohammad Taghi Report May 31, 2020 9136
Therapeutic Application of Carnitine Derivatives in Integrative Treatment of Cardiovascular Diseases. Mikolai, Jeremy Disease/Disorder overview May 1, 2020 1917
The Role of Cardiovascular Risk Assessment in Preventive Medicine: A Perspective from Portugal Primary Health-Care Cardiovascular Risk Assessment. Santos, Paulo Mar 1, 2020 4343
Conceptualization of Heterogeneity of Chronic Diseases and Atherosclerosis as a Pathway to Precision Medicine: Endophenotype, Endotype, and Residual Cardiovascular Risk. Genkel, Vadim V.; Shaposhnik, Igor I. Mar 1, 2020 7700
PERCEPTION AND PRACTICES OF HEALTHCARE PROVIDERS AND HYPERTENSIVE PATIENTS FOR ACCESSING TREATMENT OF HYPERTENSION AT A TERTIARY LEVEL HOSPITAL IN RAWALPINDI, PAKISTAN: A STUDY PROTOCOL. Subhana Akber, Assad Hafeez, Siham Sikander, Shahzad Ali Khan and Farrah Perviaz Feb 29, 2020 2342
New Diabetes Drugs a Boon for Patients with Heart Failure: SGLT2 inhibitors go above and beyond lowering blood sugar to prevent heart failure-related deaths and hospitalizations. Feb 1, 2020 712
Matinas BioPharma says Vascepa label expansion is 'ideal for the [Omega 3] class to kick off'. Dec 18, 2019 163
FDA approves Amarin fish-oil-derived drug to prevent heart attacks and strokes. Dec 16, 2019 771
Gatehouse Bio partners with AstraZeneca to accelerate new drug discovery in respiratory and cardiovascular diseases. Dec 5, 2019 175
Gatehouse Bio partners with AstraZeneca to accelerate new drug discovery in respiratory and cardiovascular diseases. Dec 5, 2019 171
Prostate Cancer Hormone Therapy Tied to Higher Heart Risk: Men on anti-androgen treatment should consult a preventive cardiologist. Dec 1, 2019 434
Significance of Myeloperoxidase in the Onset of Cardiovascular Disease among Obese Children and Adolescents. Alameey, Inas R. El-; Ahmed, Hanaa H.; Mahmoud, Rehab A.; Kairy, Sahar A.; Medany, Eman A. Report Dec 1, 2019 8634
New study involving Cypriot scientists could pave way for new heart drug. Sep 19, 2019 243
PULMONARY MEDICINE: Cardiac biomarkers predict cardiovascular events in CAP. Craven, Jeff Sep 1, 2019 569
Research Outcomes on Two Cancer Drugs. Givens, Shirley Sep 1, 2019 1180
Adverse Drug Reactions of Cardiovascular Drugs In Intensive Cardiac Care Unit In A Tertiary Care Hospital: A Prospective Study. Shanmugam, Hemanthkumar; Panneerselvam, Nithya; Lawrence, Arul Amutha Clinical report Sep 1, 2019 2614
Life on Statin Therapy: What You Should Expect: From their cardiovascular benefits to their potential side effects, here's what you need to know about these cholesterol medications. Aug 27, 2019 1281
Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster. Aug 20, 2019 1502
Hormone Therapy for Prostate Cancer Might Harm the Heart: Study. Aug 13, 2019 734
Government should give free cancer treatment. Aug 11, 2019 632
Pain medications linked to higher cardiovascular risk in osteoarthritis patients. Aug 7, 2019 321
Effect of Initial Periodontal Treatment on Cardiovascular Risk Markers in Patients with Severe Chronic Periodontitis/Siddetli Kronik Periodontitisli Hastalarda Baslangic Periodontal Tedavinin Kardiyovaskuler Risk Belirtecleri Uzerindeki Etkisi. Hendek, Meltem Karsyaka; Olgun, Ebru; Kisa, Ucler Aug 1, 2019 3738
Statin's Effects on Kidney Function May Reduce Cardiovascular Risk. Jul 25, 2019 172
Actionable findings could limit pharmacotherapy overuse. Blaha, Michael J.; Nasir, Khurram Jul 1, 2019 405
An app to help women and clinicians manage menopausal symptoms: This menopause app facilitates personalized treatment decisions. Chen, Katherine T. Medical condition overview Jun 1, 2019 591
Amarin's new drug application for vascepa granted Priority Review by FDA. May 29, 2019 209
ADA recommends cardioprotective antihyperglycemic drugs for patients. May 11, 2019 1086
Free bikes to be given out to fat people by the NHS in health bid; Regular cycling is more effective at cutting the risk of heart disease and cancer than many drugs, and now the NHS can give bike rides out on prescription. May 9, 2019 352
NSAIDs: risks and benefits. Casey, Georgina Report May 1, 2019 3593
FDA approves Sanofi/Regeneron's Praluent for cardiovascular disease. Apr 29, 2019 321
FDA Approves Tudorza Pressair (aclidinium bromide inhalation powder) Supplemental New Drug Application to include data for the Reduction of COPD Exacerbations and Hospitalizations. Apr 3, 2019 453
Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer. Smith, Dustin K.; Demetriou, Theodore; Weber, Christopher Apr 1, 2019 3782
Prescribing Trend of Antirheumatic Drugs in Taiwan and Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study. Lee, Chien-Ying; Tai, Chih-Jaan; Tsai, Ya-Fang; Kuan, Yu-Hsiang; Lee, Chiu- Hsiang; Huang, Kuang-Hua Report Mar 31, 2019 5477
Study links psoriasis treatment and improvement in heart artery disease. Mar 1, 2019 289
Breast Cancer Treatments May Increase Heart Disease Risk. Nov 1, 2018 306
The effects of cardiovascular risk factor combined anti-platelet therapy and the risk of cerebrovascular events in patients with T2DM in an urban community over 96-months follow-up: The Beijing communities diabetes study 19. Oct 31, 2018 359
Certain treatments for diabetes may lead to kidney complications: Study. Report Oct 30, 2018 308
Certain treatments for diabetes may lead to kidney complications: Study. Report Oct 30, 2018 350
Ongoing Study Traces the Expansion of Hypercholesterolemia Treatment Market During 2015-2021. Oct 29, 2018 199
Certain treatments for diabetes may lead to kidney complications. Oct 28, 2018 246
Application of Blood Pressure Guidelines Ups Treatment; Implementing ACC/AHA guideline would direct antihypertensive meds to adults at high CVD risk. Oct 9, 2018 342
Adherence to therapeutic regimen among patients with cardiovascular diseases in selected community area Dehradun, Uttarakhand. Devi, Laiphrakpam Kalpana; Prakash, Kamli; Chauhan, Vandana Report Jul 1, 2018 5009
Amarin enters collaboration with Mochida. Jun 12, 2018 263
Novel approaches to lipid-lowering therapy. Brozin, D.; Raal, F.J. Report Apr 1, 2018 3244
Study: Common Cholesterol and Blood Pressure Drugs Don't Cause ED. Apr 1, 2018 163
Q / What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events? Mutter, Justin; Grandy, Rebecca; Hulkower, Stephen; Stigleman, Sue; Guthmann, Rick Report Apr 1, 2018 1038
A comparison between intravenous metoprolol and labetalol in prevention of cardiovascular stress response to laryngoscopy and intubation. Swami, Nishee R.; Badhe, Vaishalee K.; Deshpande, Vaishali V.; Badhe, Vaijayanti K.; Vinayak, Shidha Report Apr 1, 2018 5075
Usefulness of alirocumab and evolocumab for the treatment of patients with diabetic dyslipidemia. Zhang, Jun; Tecson, Kristen M.; Rocha, Natalia A.; McCullough, Peter A. Report Apr 1, 2018 3825
Diabetes drug can reduce risk of heart and kidney disease. Mar 22, 2018 287
Diabetes drug can reduce risk of heart and kidney disease. Mar 22, 2018 249
New heart disease treatments in focus. Jan 18, 2018 202
Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis. Batzias, Konstantinos; Antonopoulos, Alexios S.; Oikonomou, Evangelos; Siasos, Gerasimos; Bletsa, Ev Report Jan 1, 2018 7182
Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens. Yersal, Ozlem; Eryilmaz, Ufuk; Akdam, Hakan; Meydan, Nezih; Barutca, Sabri Jan 1, 2018 4072
Corrigendum to "The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases". Chen, Shuang; Jiang, Hongmei; Peng, Hanhui; Wu, Xiaosong; Fang, Jun Correction notice Jan 1, 2018 862
The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease. Wen, Ya-Dan; Wang, Hong; Zhu, Yi-Zhun Jan 1, 2018 17863
How to target PCSK9 inhibitors to reap most benefit. Jancin, Bruce Dec 1, 2017 1181
Second Diabetes Drug Found to Protect Against Heart Attack and Stroke. Dec 1, 2017 181
Impact of Proton-pump Inhibitors on the Pharmacodynamic Effect and Clinical Outcomes in Patients Receiving Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: A Propensity Score Analysis. Zhu, Pei; Gao, Zhan; Tang, Xiao-Fang; Xu, Jing-Jing; Zhang, Yin; Gao, Li-Jian; Chen, Jue; Qiao, Shu- Report Dec 1, 2017 3736
PREVENTION OF CARDIOVASCULAR DISEASES--PROPHYLACTIC PROGRAM IN A SELECTED ENTERPRISE/ZAPOBIEGANIE CHOROBOM UKLADU KRAZENIA PROGRAM PROFILAKTYCZNY WDROZONY W WYBRANYM PRZEDSIEBIORSTWIE. Siedlecka, Jadwiga; Gadzicka, Elzbieta; Szyjkowska, Agata; Siedlecki, Patryk; Szymczak, Wieslaw; Mak Report Nov 1, 2017 7218
The vital stats on statins; Your guide to controversial drugs' ups & downs. Oct 25, 2017 1019
Pericarditis may be easier to treat with new medications: two new drugs look promising in the fight to stop this painful inflammation of the sac that surrounds the heart. Sep 1, 2017 348
HEART WONDER DRUG; 'Biggest breakthrough since statins' could also cut deaths from cancer. Aug 28, 2017 229
HEART WONDER DRUG; 'Biggest breakthrough since statins' could also cut deaths from cancer. Aug 28, 2017 234
HEART WONDER DRUG; 'Biggest breakthrough since statins' could also cut deaths from cancer. Aug 28, 2017 234
Sex-specific cardiovascular drug dosages necessary to reduce and prevent adverse reactions in women. Jun 16, 2017 515
AstraZeneca type-2 diabetes drug Bydureon meets primary safety objective. May 23, 2017 206
AstraZeneca type-2 diabetes drug Bydureon meets primary safety objective. May 23, 2017 202
Diabetes drug can reduce risk of heart, kidney disease. Apr 28, 2017 293
Drug utilisation study of cardiac emergency patients in a tertiary care hospital. Hannan, Abdul; Sinha, Shyamal; Jamadar, Pravin Report Apr 3, 2017 5305
Protect your heart if you have type 2 diabetes: newer medications and aggressive risk-factor management may lower cardiac risk among diabetes patients. Feb 1, 2017 1348
Jardiance granted cardiovascular indication. Jan 2, 2017 349
Use of Pharmacogenetic Information in the Treatment of Cardiovascular Disease. Friede, Kevin; Li, Josephine; Voora, Deepak Report Jan 1, 2017 7657
The Light and Shadow of Senescence and Inflammation in Cardiovascular Pathology and Regenerative Medicine. Iop, Laura; Sasso, Eleonora Dal; Schirone, Leonardo; Forte, Maurizio; Peruzzi, Mariangela; Cavarrett Report Jan 1, 2017 10373
Regulation of Corticosteroidogenic Genes by MicroRNAs. Robertson, Stacy; Diver, Louise A.; Alvarez-Madrazo, Samantha; Livie, Craig; Ejaz, Ayesha; Fraser, R Report Jan 1, 2017 5721
Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient Rat. Posa, Aniko; Szabo, Renata; Kupai, Krisztina; Berko, Aniko Magyarine; Veszelka, Medea; Szucs, Gergo; Report Jan 1, 2017 6278
Evaluation of Anti-Inflammatory Properties of Isoorientin Isolated from Tubers of Pueraria tuberose. Anilkumar, Kotha; Reddy, Gorla V.; Azad, Rajaram; Yarla, Nagendra Sastry; Dharmapuri, Gangappa; Sriv Report Jan 1, 2017 5610
The Clinical Efficacy of Yindanxinnaotong Soft Capsule in the Treatment of Stroke and Angina Pectoris: A Meta-Analysis. Cheng, Long; Liu, Yue; Sun, Xiao-bo Report Jan 1, 2017 10022
Eli Lilly and Company wins US FDA approval for new indication for Jardiance tablets to reduce risk of cardiovascular death in type 2 diabetes patients. Dec 6, 2016 288
Eli Lilly and Company wins US FDA approval for new indication for Jardiance tablets to reduce risk of cardiovascular death in type 2 diabetes patients. Dec 6, 2016 284
Empagliflozin first antidiabetes drug to gain cardioprotective indication. Sullivan, Michele G. Dec 1, 2016 408
Public sector participation in the supply of dyslipidemia medication in a population-based study/Participacao do setor publico no fornecimento de medicamentos para dislipidemias em estudo de base populacional. Petris, Airton Jose; de Souza, Regina Kazue Tanno; Bortoletto, Maira Sayuri Sakay Ensayo Dec 1, 2016 5106
Cardiovascular risk associated with antipsychotic treatment. Mitu, Florin; Pila, Ionica; Mitu, Ovidiu; Gavril, Radu; Roca, Mihai; Jitaru, Alexandra; Leon, Magdal Report Dec 1, 2016 2650
Consider comorbidities in psoriasis treatment for better outcomes. McKnight, Whitney Nov 1, 2016 464
Ethical considerations in clinical research on herbal medicine for prevention of cardiovascular disease in the ageing. Koonrungsesomboon, Nut; Karbwang, Juntra Sep 28, 2016 5901
Would an empagliflozin CVD indication make a difference? Zoler, Mitchel L. Aug 1, 2016 876
The role of Statins in the Athero-Sclerosis, Heart attacks and Strokes. Jul 31, 2016 825
The end of polypill--statins for everyone. Goldstein, Sidney Jul 1, 2016 556
Prompt antidepressant treatment swiftly chopped cardiovascular risk. Jancin, Bruce Jun 1, 2016 533
HOPE-3 supports broader preventive role for statins. Jancin, Bruce Apr 15, 2016 1061
Newcastle professor claims walking is a 'wonder drug' to beat cancer, heart disease and strokes; A Newcastle City Council professor has said that if walking were a drug it would be 'the most valuable' in the world. Mar 31, 2016 333
Anti-smoking drug doesn't trigger heart disease, depression. Dec 18, 2015 178
FDA approves new heart failure medication: research suggests the new drug helps reduce heart failure-related hospitalizations and deaths due to cardiovascular disease. Sep 1, 2015 544
Pharmacogenomic determinants of response to cardiovascular drugs/Uloga farmakogenomskih faktora u odgovoru na kardiovaskularne lekove. Stankov, Karmen M.; Stanimirov, Bojan G.; Mikov, Momir M. Report Jul 1, 2015 5291
Extra help from ezetimibe: if you need further LDL reduction or can't tolerate statins, adding this drug may lower your cardiovascular risk. Jun 1, 2015 725
Anticipation high for coming cardiology megatrials. Jancin, Bruce Apr 15, 2015 1370
Evolocumab therapy halved CVD events. Jancin, Bruce Clinical report Apr 1, 2015 1146
Digoxin therapy in the modern management of cardiovascular disease: an unusual but serious complication. Mkoko, P.; Mokhele, N.; Ntsekhe, M.; Ntusi, N.A.B. Clinical report Feb 1, 2015 1065
Naturopathic medicine and cardiovascular disease. Klotter, Jule Feb 1, 2015 658
Use of Atorvastatin in Lipid Disorders and Cardiovascular Disease in Chinese Patients. Ye, Yi-Cong; Zhao, Xi-Liang; Zhang, Shu-Yang Report Feb 1, 2015 6321
Gene therapy set to become future of heart disease treatment. Oct 9, 2014 310
Cardiovascular risks overlooked in antidiabetes drug trials. Kessler, A. Brief article Sep 1, 2014 178
New insights into the statin-cholesterol controversy. Marshall, Timothy M. Jun 22, 2014 4772
Production of New Type of Electrochemical Drug Sensors for Cardiovascular Diseases. Mar 10, 2014 213
FDA investigating testosterone's cardiovascular risks. Boschert, Sherry Feb 15, 2014 429
Diuretics, beta-blockers and statins and new-onset type 2 diabetes. Abstract Feb 1, 2014 307
Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models. Szalai, Alexander J.; McCrory, Mark A.; Xing, Dongqi; Hage, Fadi G.; Miller, Andrew; Oparil, Suzanne Clinical report Jan 1, 2014 5825
Cellular and molecular studies of the effects of a selective COX-2 inhibitor celecoxib in the cardiac cell line H9c2 and their correlation with death mechanisms. Sakane, K.K.; Monteiro, C.J.; Silva, W.; Silva, A.R.; Santos, P.M.; Lima, K.F.; Moraes, K.C.M. Report Jan 1, 2014 6111
G3, Metabolon join hands on cardiovascular disease biomarkers, drug targets discovery study. Clinical report Nov 15, 2013 248
Panel: omega-3 pill needs more CV outcomes data. Mechcatie, Elizabeth Nov 1, 2013 1049
More bad news for testosterone therapy. Report Nov 1, 2013 449
Statin drugs are highly effective against cardiovascular disease: statins help prevent heart attacks and strokes by reducing LDL cholesterol and slowing plaque buildup. Nov 1, 2013 884
Gene therapy set to become future of heart disease treatment. Oct 9, 2013 310
Gene therapy set to become future of heart disease treatment. Oct 7, 2013 329
Papillary Renal Cell Carcinoma in a patient with renal transplant. Aug 31, 2013 1644
Common acid reflux drug could cause heart disease. Jul 14, 2013 205
Drug development: the lottery that you pay for. Gaby, Alan R. Editorial Jun 1, 2013 991
HPS2-THRIVE drives another nail in niacin's coffin. Jancin, Bruce Apr 15, 2013 868
FDA panel backs canagliflozin for type 2 diabetes: committee votes 10-5 for approval, but some cite safety concerns and cardiovascular risks. Mechcatie, Elizabeth Feb 1, 2013 1328
FDA issues cardiovascular safety update for Chantix. Mechcatie, Elizabeth Report Jan 1, 2013 447
Effects of statin drugs on atherosclerosis and cardiovascular disease due to reductase inhibition and nutrient depletions. Martin, Brett R.; Richardson, Daniel L. Sep 1, 2012 3720
NIH launches trial to evaluate anti-inflammatory treatment for preventing heart attacks, strokes, and cardiovascular deaths. Brief article Aug 22, 2012 118
Statin could reduce disability and prolong life expectancy in elderly. Jul 13, 2012 473
Cardiovascular diseases will remain No. 1 cause of death globally-Prof Akbar Chaudhry. Report Jun 30, 2012 969
Stealth Peptides begins patient enrolment for treatment of cardiovascular disease and reperfusion injury. Clinical report Jun 25, 2012 127
Stealth Peptides begins patient enrolment for treatment of cardiovascular disease and reperfusion injury. Clinical report Jun 25, 2012 123
Diabetics missing out on vital drug , shows survey. May 14, 2012 434
How pain medication Vioxx ups heart disease risk. May 3, 2012 834
Statins may help lower depression risk: the key could be that the medication reduces atherosclerosis in the brain. Jiang, Wei Clinical report May 1, 2012 693
Veno-active drugs in the management of chronic venous disease. An international consensus statement: current medical position, prospective views and final resolution. Brief article May 1, 2012 206
AstraZeneca partners with The Medicines Company for Acute Ischemic Heart Disease, including promoting BRILINTA in the US. Apr 26, 2012 200
Women in India do not receive same treatment as men for heart disease. Apr 21, 2012 348
New psoriasis drug reduces vessel inflammation. Wachter, Kerri Apr 15, 2012 687
NASAL SPRAY COULD BEAT HEART DISEASE; Treatment removes fat from arteries. Apr 2, 2012 267
What you should know about statin use after menopause: potential risks do not outweigh known benefits. Apr 1, 2012 639
Trimetazidine: the heart drug you've never heard of. Peer Reviewed, Carl DeMarco; Strum, Stephen B. Report Apr 1, 2012 5396
Doubts cast over effectiveness of bone marrow treatment for heart failure. Clinical report Mar 25, 2012 516
Arthritis pill could hold key to beating heart disease. Mar 14, 2012 193
Questions asked over aspirin use; Credited with reducing strokes and the risk of bowel cancer, as well as headaches, aspirin is our latest wonder drug. But could a daily dose do more harm than good? RACHEL WEARMOUTH reports. Feb 27, 2012 726
New method to regrow blood vessels could benefit heart disease treatment. Feb 17, 2012 215
New insight into rheumatoid arthritis management: the disease and the drugs used to treat it have been linked to cardiovascular disease, melanoma, and fracture. Feb 1, 2012 821
An evaluation of the effects of EDTA chelation therapy for the treatment of cardiovascular disease and associated conditions. Martin, Brett R.; Richardson, Daniel L. Report Dec 1, 2011 9051
Cardiovascular patients need more treatment. Nov 21, 2011 481
'Shocking percentage' on triptans despite risks: fully 22% of patients with cardiac contraindications to triptans had received a prescription for the drug. Bates, Betsy Nov 1, 2011 901
Body of work: Molly Shoichet is the leading researcher at University of Toronto's new Centre for the Commercialization of Regenerative Medicine, creating technologies to treat and possibly cure diabetes, cancer, heart disease and spinal cord injuries. Calamai, Peter Cover story Nov 1, 2011 1424
Patients' cardiac disease fails to stop triptan prescriptions. Bates, Betsy Nov 1, 2011 648
Analysis suggests DDP-4 inhibitors may be cardioprotective. Sullivan, Michele G. Oct 15, 2011 650
Dipeptidyl peptidase-4 inhibitors may be cardioprotective. Sullivan, Michele G. Report Oct 1, 2011 733
Possible cardiovascular risk with NSAIDs use needs further probe. Sep 27, 2011 284
Cardiovascular disease treatment improves sexual function in men with ED. Sep 15, 2011 341
Statins for patients with nonalcoholic fatty liver? Although physicians often avoid prescribing statins for patients with nonalcoholic fatty liver, their use has been found to reduce cardiovascular morbidity and mortality - and to lower liver enzymes. Egan, Mari; Prasad, Shailendra Sep 1, 2011 1584
Pleuropericarditis associated with sulphasalazine in a case of rheumatoid arthritis: a drug-induced lupus-like syndrome / romatoid artritli bir olguda sulfasalazinle iliskili ploroperikardit: ilac kaynakli lupus benzeri sendrom. Hiz, Ozcan; Gulcu, Elif; Ozkan, Yasemin; Tekeoglu, Ibrahim; Aladag, Nesim Report Sep 1, 2011 2427
Soon, a 'red wine wonder pill' to cure obesity, diabetes, heart disease, cancer. Aug 19, 2011 326
Cardiovascular risk reduction in CKD patients: let's get SHARP! Thomas, Alison Jul 1, 2011 1288
Even short-term NSAID use is risky after MI. Mechcatie, Elizabeth Jun 1, 2011 580
Short-term NSAID use appears risky after MI. Mechatie, Elizabeth Jun 1, 2011 551
Natural approaches to modulation of inflammatory pathways. Wolfson, David; Olmstead, Stephen; Meiss, Dennis; Ralston, Janet Report Jun 1, 2011 5748
Even short-term NSAID use raises death/recurrent MI risk. Mechcatie, Elizabeth Jun 1, 2011 649
All NSAIDS carry cardiovascular risks. Apr 1, 2011 128
Lowering BP in acute stroke showed no benefit. Sullivan, Michele G. Report Mar 1, 2011 685
Clinical update: antiplatelet therapy: role of Effient[R] (prasugrel). Mehran, Roxana; Galper, Benjamin Z.; Dangas, George D. Clinical report Dec 1, 2010 2740
Add a fibrate to a statin: for most patients with diabetes and dyslipidemia, adding a fibrate does not improve cardiovascular outcomes. Lounsbery, Jody; Prasad, Shailendra; Rowland, Kate Clinical report Oct 1, 2010 1570
Statin drugs produce unintentional harmful results. Brief article Sep 22, 2010 104
Prostate cancer drugs' safety in question: links with heart disease and diabetes have resulted in FDA review of the drugs' safety. Kelly, James R. Aug 1, 2010 1022
Cardiovascular risks mount with certain anti-inflammatory drugs: diclofenac is cited as the most dangerous anti-inflammatory drug. Aug 1, 2010 753
Prostate cancer drugs could pose risk to heart health: FDA reviewing safety of anti-hormone treatments due to links with heart disease and diabetes. Aug 1, 2010 602
No link between diabetes drug and rise in heart attacks. Jun 30, 2010 532
Some PCOS treatments can reduce cardiovascular risk. Boschert, Sherry Clinical report May 1, 2010 392
Do beta blockers cause depression? Muzyk, Andrew J.; Gagliardi, Jane P. Clinical report May 1, 2010 1286
Aspirin does not prevent events in low ABI patients. Moon, Mary Ann Mar 15, 2010 497
Unaddressed cardiovascular risks prove fatal. Susman, Jeffrey L. Brief article Mar 1, 2010 137
US-approved drug could reduce cardiovascular diseases in UAE. Feb 26, 2010 361
Antiretrovirals may increase cardiovascular risk. Boschert, Sherry Feb 15, 2010 740
CVD contraindication for sibutramine. Brief article Feb 15, 2010 118
Antiretrovirals may alter cardiovascular risk profile. Boschert, Sherry Report Feb 15, 2010 739
New rosuvastatin indication backed. Brief article Jan 1, 2010 201
Aspirin for primary CVD prevention should not be initiated routinely. Abstract Dec 1, 2009 204
Telmisartan approved for high-risk patient indication. Mechcatie, Elizabeth Nov 15, 2009 492
Prostate cancer patients on hormone therapy 'at increased heart disease risk'. Sep 23, 2009 451
New model to find optimum time for statin therapy in diabetes patients. Aug 15, 2009 348
It's never 'just diabetes'. Cornell, Susan Report Aug 3, 2009 571
Statins for all--with established cardiovascular risk factors. Farham, Bridget Brief article Aug 1, 2009 260
Do you need aspirin therapy? Your risks of heart attack and stroke based on your current and past medical history must be weighed against the chances of internal bleeding. Aug 1, 2009 468
New nanoparticle may revolutionise cardiovascular disease treatment. Jun 5, 2009 418
Anti-seizure drugs may raise cardiovascular risks. Clinical report May 1, 2009 163
Debut of 5-in-1 polypill spurs therapeutic debate. Zoler, Mitchel L. May 1, 2009 820
Statin lowers risk of cardiovascular and VTE events: cuts in CRP, LDL were both beneficial. Zoler, Mitchel L. Apr 15, 2009 1285
Guidelines spell out prophylactic aspirin use. Sullivan, Michele G. Apr 15, 2009 586
A reduction in cardiovascular risk is the main aim of most lipid-modifying therapy. Rajput, M. Chiman Report Mar 1, 2009 2845
Generic drugs ok'd for cardiovascular disease. Feb 1, 2009 127
Generic heart medicines found equal to brand-name counterparts. Brief article Dec 8, 2008 316
Statin curbs events in elevated CRP. Helwick, Caroline Dec 1, 2008 955
Inflammatory marker tied to CV mortality. Zoler, Mitchel L. Clinical report Oct 15, 2008 523
AstraZeneca Plc's cholesterol drug Crestor has failed in a second clinical trial for heart failure, suggesting such statin medicines don't improve survival in patients with the chronic condition. Brief article Sep 8, 2008 255
Major CV events not decreased with Vytorin. Macneil, Jane Salodof Aug 15, 2008 1104
AstraZeneca Plc's Toprol XL, given before surgery to prevent heart complications, increases the danger of stroke or death, researchers said. Brief article May 19, 2008 210
Metabolic syndrome not a factor in aspirin resistance in chronic Tx. Wendling, Patrice Clinical report May 15, 2008 552
Combined drug treatments could save more lives: study shows the key to fighting heart disease could be combination drugs. May 1, 2008 462
Effects of aqueous hop (Humulus Lupulus L.) extract on vascular reactivity in rats: mechanisms and influence of gender and hormonal status. Figard, H.; Girard, C.; Mougin, F.; Demougeot, C.; Berthelot, A. Report Mar 1, 2008 5125
Statin therapy goes beyond lowering cholesterol: the anti-inflammatory benefits of statin therapy also seem to help prevent dementia and slow lung function decline. Feb 1, 2008 761
Role of quercetin in cardiovascular diseases. Lakhanpal, Parul; Rai, Deepak Kumar Clinical report Jan 1, 2008 11044
Consider alternatives to controversial drug: if you're concerned about using rosiglitazone for your diabetes, a leading heart expert recommends talking to your doctor about other options to control your blood sugar. Oct 1, 2007 631
Target body fat early to lower kids' CVD risks. (Cardiovascular Medicine). Worcester, Sharon Aug 15, 2007 953
Statins alleviate vascular disease, stymie ulcers in systemic sclerosis. Walsh, Nancy Jul 15, 2007 454
Aggressive statin therapy beneficial for elderly patients: low LDL tied to lower cardiac event rate. Beck, Debra L. May 15, 2007 570
CVD duet offers benefits. May 1, 2007 241
FDA approves first new blood pressure drug in 10 years. Brief article May 1, 2007 136
Zelnorm pulled off the shelf due to possible cardiovascular risk signal. Ault, Alicia Apr 15, 2007 346
Folic acid supplements said to not lower heart risk. Brief article Apr 1, 2007 156
Integrating fish oil with prescription heart medications. Scozzari, James S. Report Apr 1, 2007 478
Rofecoxib, diclofenac, and indomethacin increase risk of CVD. McGettigan, P.; Henry, D. Dec 1, 2006 409
How useful are [beta]-blockers in cardiovascular disease?/Kardiyovaskuler hastaliklarda [beta]-blokerler ne kadar yararli? Bangalore, Sripal; Parkar, Sanobar; Messerli, Franz H. Clinical report Dec 1, 2006 5436
Further benefit of pioglitazone seen in high-risk type 2 patients. Nov 1, 2006 535
Cardiologists enlisted to fight flu: your heart doctor may offer a protective shot. Here's why that's a good idea. Nov 1, 2006 437
Atorvastatin stems stroke recurrence. Brief article Oct 1, 2006 225
Antihypertensive drugs for CVD. Weir, Matthew R.; Wexler, Randy; Feldman, David Oct 1, 2006 2166
How caring for your heart will change: among 7 expert predictions: larger waistlines, doctor shortages and new medications. Sep 1, 2006 1030
Imaging methods unveil rupture-prone plaque. Jancin, Bruce Disease/Disorder overview Aug 1, 2006 581
Early initiation of statins following ACS does not improve outcomes. Briel, M.; Schwartz, G.G.; Thompson, P.L. Aug 1, 2006 335
Supplement aims at cardio risks. Jun 19, 2006 258
Aggressive use of statins lowers post-ACS mortality. Jancin, Bruce Clinical report Jun 15, 2006 500
The latest drugs on the FDA's radar: expect labeling changes for the stimulants. Waldron, Theresa Jun 1, 2006 1160
Vytorin lowers C-reactive protein. Jancin, Bruce Jun 1, 2006 460
Does stopping a statin increase the short-term risk of a cardiovascular event? Crawford, Paul; Hitchcock, Kristin Drug overview Jun 1, 2006 1221
Class of antihypertensive unimportant if it works. Jancin, Bruce Apr 15, 2006 567
Protecting the circulatory system. Zimmerman, Philip W. Mar 22, 2006 623
Trastuzumab's cardiovascular risk can be cut. Jancin, Bruce Feb 15, 2006 1271
Aspirin reduces cardiovascular deaths in women. Jancin, Bruce Brief Article Jan 15, 2006 234
Investigational stent falls short on key end point. Ault, Alicia Jan 15, 2006 615
Aspirin cuts CV mortality by 25% in women. Jancin, Bruce Jan 15, 2006 314
Drug-eluting stents: worth the money? Jancin, Bruce Nov 15, 2005 595
Lifestyle factors may affect gene carriers' AD risk. Evans, Jeff Brief Article Nov 1, 2005 246
CV biomarkers not set for wide use. Boschert, Sherry Oct 15, 2005 382
Fewer CV events seen with combo blood pressure Tx; amlodipine plus perindopril saved lives. Zoler, Mitchel L. Oct 1, 2005 948
FDA panel recommends muraglitazar alone, with metformin. Tucker, Miriam E. Oct 1, 2005 906
Patients err in warfarin adherence 22% of days. Tucker, Miriam E. Aug 1, 2005 376
Predicted drop in NSAID use may prompt clinical changes. Jancin, Bruce Jul 15, 2005 1008
Rimonabant may benefit Type 2 diabetes patients: cardiovascular risk factors lessened. Tucker, Miriam E. Jul 15, 2005 1106
Implications of expected big drop in NSAID use: cardiovascular side effects likely to cause physicians to seek other options for chronic pain management. Jancin, Bruce Jul 15, 2005 766
Sarcoplasmic reticulum and caveolae proteins in the aged rat myocardium. Gurney, Lynn; Rencher, Logan; Cusack, Barry; Olson, Richard; Gambliel, Herve Brief Article Jun 1, 2005 230
Findings put new spin on HT combo therapy. Jancin, Bruce Jun 1, 2005 360
Keep aspirin below 100 mg/day for vascular events. Jancin, Bruce May 15, 2005 736
Panel backs candesartan-ACE inhibitor combo: treating 1,000 patients with candesartan avoided 1,900 days in the hospital for worsening heart failure. Mechcatie, Elizabeth Apr 15, 2005 836
Rimonabant weight loss sustained at 2 years. Jancin, Bruce Apr 15, 2005 820
Don't commit to quick [beta]-blocker in MI. Apr 15, 2005 602
CV risk persists in atorvastatin Tx of type 2 diabetics on dialysis. Ingram, Jerry Apr 15, 2005 407
FDA now reviewing panel's nod to COX-2s: celecoxib garnered nearly unanimous support; vote was more divided on rofecoxib and valdecoxib. Mechcatie, Elizabeth Apr 1, 2005 1211
Questions linger about proper use of COX-2 inhibitors: FDA panel sees role for drugs despite risks. Mechcatie, Elizabeth Mar 15, 2005 1440
DVT prophylaxis underused in acutely ill patients: recommendations are not followed for most inpatients, registry data show. Brunk, Doug Mar 15, 2005 459
Rimonabant markedly improves cardiovascular risk profile. Jancin, Bruce Feb 1, 2005 681
Omega-3 fatty acids available in prescription form. Ault, Alicia Brief Article Feb 1, 2005 277
Aspirin used incorrectly for cardioprotection. Worcester, Sharon Feb 1, 2005 655
New data cloud issue of COX-2 class effect: studies suggest that the various COX-2 inhibitors pose different risks for the cardiovascular system. Ault, Alicia Jan 15, 2005 905
Move quickly to high-dose statin after MI. Zoler, Mitchel L. Dec 1, 2004 1142
Catheter ablation for atrial fib sometimes disappoints. Zoler, Mitchel L. Nov 15, 2004 630
Framingham risk favored over European SCORE. Zoler, Mitchel L. Oct 15, 2004 1333
Should we prescribe a 'Polypill' to everyone at increased risk of CV disease and to those over age 55? Rodgers, Anthony; Blackburn, Henry Oct 1, 2004 845
Acarbose appears to reduce cardiovascular events: impaired glucose tolerance. Zoler, Mitchel L. Brief Article Nov 1, 2003 290
Everolimus superior to azathioprine for cardiac allograft vasculopathy. Sep 15, 2003 457
Is routine ACE inhibitor therapy warranted in patients at high risk for cardiovascular events? (Pro & Con). Sep 1, 2002 888
SSRIs supply antiplatelet bonus in heart disease: Select SSRIs reduced MI risk by 41%. (Depressed Cardiac Patients). Zoler, Mitchel L. Brief Article May 1, 2002 554
Enoxaparin (Lovenox[R]): an effective and convenient anticoagulant. (Nursing Pharmacology). Mullaney, Stephen; Letizia, Marijo; Jennrich, Judith Dec 1, 2001 1971
ACE Inhibitors to Prevent Cardiovascular Events in High-Risk Patients. VandeKieft, Gregg K. Apr 1, 2000 684
Statin Plus Niacin Helps Most Lipid Disorders. ZWILLICH, TODD Brief Article Sep 15, 1999 591
Lion's share of R&D goes to heart drugs. Jan 28, 1991 136

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters